GLIMTYT M1 – Advanced oral antidiabetic tablets by Israelites Pharma, formulated to support effective blood sugar management, enhance insulin sensitivity, and promote long-term metabolic health.
At Israelites Pharma, we bring scientifically advanced, safe, and affordable pharmaceutical solutions designed for effective diabetes management. The GLIMTYT range helps regulate blood glucose levels, improve insulin utilization, and support overall metabolic and cardiovascular health. Trusted by healthcare professionals and patients for its proven efficacy and safety.
| Attribute | GLIMTYT M1 | GLIMTYT M2 | GLIMTYT M4 FORTE |
|---|---|---|---|
| Dosage Form | Tablet | Tablet | Tablet |
| Strength | 1 MG + 500 MG | 2 MG + 500 MG | 4 MG + 1000 MG |
| Packaging Options | 10 Tablets per Strip, 10 Strips in Box | 10 Tablets per Strip, 10 Strips in Box | 10 Tablets per Strip, 10 Strips in Box |
| Therapeutic Area | Cardiovascular / Diabetic | Cardiovascular / Diabetic | Cardiovascular / Diabetic |
| Storage | Cool, dry place | Cool, dry place | Cool, dry place |
| Recommended Use | As directed by a healthcare professional | As directed by a healthcare professional | As directed by a healthcare professional |
| Manufacturer | Akums Drugs, Himachal Pradesh, India | Akums Drugs, Himachal Pradesh, India | Logos Pharmaceuticals, Himachal Pradesh, India |
| Ingredients | Glimepiride 1 MG + Metformin 500 MG | Glimepiride 2 MG + Metformin 500 MG | Glimepiride 4 MG + Metformin 1000 MG |
| Image / Documents | Link | Link | Link |
GLIMTYT M1 and GLIMTYT M2 are manufactured by Akums Drugs & Pharmaceuticals Ltd, and GLIMTYT M4 FORTE is manufactured by Logos Pharmaceuticals, both located in Himachal Pradesh, India.
All facilities comply with Good Manufacturing Practices (GMP) and utilize modern pharmaceutical technology to maintain high standards of quality, consistency, safety, and efficacy.
Both facilities adhere to Good Manufacturing Practices (GMP) and utilize advanced pharmaceutical technology to ensure the highest standards of quality, consistency, safety, and efficacy in every batch produced.
The product range is marketed by Israelites Pharma Pvt Ltd, located at A/321, Royal Palms, Goregaon East, Mumbai, Maharashtra – 400065, India.
Israelites Pharma remains dedicated to delivering safe, effective, and affordable diabetic care solutions, while upholding ethical practices and full regulatory compliance.
Every GLIMTYT batch undergoes stringent quality testing for purity, safety, and efficacy. Production follows detailed Standard Operating Procedures (SOPs) supervised by an expert team of pharmaceutical professionals and quality analysts.
Israelites Pharma’s R&D team continuously develops innovative diabetic formulations and clinical research-based therapies, ensuring products like GLIMTYT align with modern standards of glucose and metabolic control.
Israelites Pharma prioritizes patient-centric healthcare, ensuring all medicines are scientifically tested, ethically produced, and clinically reliable. The company’s commitment to transparency, trust, and long-term wellness reinforces confidence among healthcare providers and patients.
Combines Glimepiride 1 MG and Metformin 500 MG to effectively control blood sugar and improve insulin sensitivity.
Dual therapy with Glimepiride 2 MG and Metformin 500 MG supports stable glucose levels and metabolic health.
Advanced formulation of Glimepiride 4 MG and Metformin 1000 MG provides strong, long-lasting glycemic control for diabetes management.
WhatsApp us